Achieve Life Sciences (ACHV) Shares Issued (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Shares Issued came in at $5.0 million in Q1 2026, up 119.55% YoY from $2.3 million in Q1 2025, and up 82.06% on a QoQ basis from $2.7 million in Q4 2025.
Achieve Life Sciences (ACHV) Shares Issued (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Shares Issued data on file, last reported at $5.0 million in Q1 2026.
- Quarterly Shares Issued rose 119.55% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 119.55% YoY) and the FY2025 annual result came in at $2.7 million, up 27.61% from the prior year.
- Shares Issued grew to $5.0 million in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $5.0 million in Q1 2026 to a low of $789940.0 in Q1 2022.
- A 5-year average of $1.8 million and a median of $1.9 million in 2024 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2025 — Shares Issued climbed 9.63% — and 2026, when it jumped 119.55%.
- Tracing ACHV's Shares Issued over 5 years: stood at $822515.0 in 2022, then jumped by 77.75% to $1.5 million in 2023, then soared by 46.34% to $2.1 million in 2024, then climbed by 27.61% to $2.7 million in 2025, then soared by 82.06% to $5.0 million in 2026.
- The last three Shares Issued figures came in at $5.0 million (Q1 2026), $2.7 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | 9.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.30 Mn |
| Jun 30, 2026 | 9.30 Mn |
| Mar 31, 2026 | 4.97 Mn |
| Mar 31, 2026 | 4.97 Mn |
| Dec 31, 2025 | 2.73 Mn |
| Dec 31, 2025 | 2.73 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Mar 31, 2025 | 2.26 Mn |
| Mar 31, 2025 | 2.26 Mn |
| Dec 31, 2024 | 2.14 Mn |
| Dec 31, 2024 | 2.14 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Mar 31, 2024 | 1.93 Mn |